Effect of Depression Treatment on Somatic Depressive Symptoms and Cardiometabolic Biomarkers among People without Diabetes

Examining the effect of a modernized collaborative care intervention for depression consisting of both behavioral and pharmacologic treatments on 12-month change in individual somatic depressive symptoms (hyperphagia, poor appetite, hypersomnia, and disturbed sleep) and 12-month change in

cardiometabolic biomarkers (HOMA-IR, BMI, hsCRP, leptin, and ghrelin). Further examining whether 12-month change in individual somatic depressive symptoms mediates the eIMPACT intervention’s effect on 12-month change in cardiometabolic biomarkers.